Corvidia Therapeutics is a startup based in the United States, most recent round Acquired, 3 tracked investors.
Corvidia Therapeutics is a startup based in the United States. Corvidia Therapeutics has been acquired. Brouky records 3 investors associated with the company.
Corvidia Therapeutics was a biopharmaceutical company that developed ziltivekimab, an anti-IL-6 ligand monoclonal antibody aimed at reducing inflammation-driven cardiovascular risk in patients with chronic kidney disease. The company was acquired by Novo Nordisk (stage: acquired).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.